Overview
Mona Wu practices in Montreal, Canada. Ms. Wu is rated as an Advanced expert by MediFind in the treatment of DICER1 Syndrome. Her top areas of expertise are DICER1 Syndrome, Pleuropulmonary Blastoma, Adult Soft Tissue Sarcoma, and Renal Cell Carcinoma (RCC).
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of DICER1 Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- DICER1 SyndromeMs. Wu isAdvanced. Learn about DICER1 Syndrome.
- Experienced
- Adult Soft Tissue SarcomaMs. Wu isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Pleuropulmonary BlastomaMs. Wu isExperienced. Learn about Pleuropulmonary Blastoma.
- Renal Cell Carcinoma (RCC)Ms. Wu isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Sertoli-Leydig Cell TumorMs. Wu isExperienced. Learn about Sertoli-Leydig Cell Tumor.